{"nctId":"NCT00604019","briefTitle":"Dopamine Versus Norepinephrine for the Treatment of Vasopressor Dependent Septic Shock","startDateStruct":{"date":"2003-03"},"conditions":["Septic Shock"],"count":252,"armGroups":[{"label":"Dopamine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Dopamine"]},{"label":"Norepinephrine","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Norepinephrine"]}],"interventions":[{"name":"Dopamine","otherNames":[]},{"name":"Norepinephrine","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Patients are transferred to our medical intensive care unit from the emergency room (ER), general medical floors, and from outside hospitals.\n* Patients were eligible if they were greater than 18 years of age\n* Presented with a diagnosis of SIRS plus a suspected or documented source of infection.\n\nExclusion Criteria:\n\n* Patients were not eligible if they were found to have hypovolemic and/or hemorrhagic etiologies of their vasodilatory shock or another etiology of their SIRS.","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Efficacy and Safety of Dopamine Versus Norepinephrine in Septic Shock","description":"We measured 28 day all-cause mortality in randomized patients with septic shock managed with a vasopressor protocol containing either dopamine versus norepinephrine.","paramType":"NUMBER","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"67","spread":null},{"groupId":"OG001","value":"51","spread":null}]}]}]},{"type":"SECONDARY","title":"Safety, Arrythmia - Yes or no for Each Group","description":"We evaluated adverse events including arrhythmias in the two vasopressor protocol study groups","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"51","spread":null},{"groupId":"OG001","value":"14","spread":null}]},{"measurements":[{"groupId":"OG000","value":"83","spread":null},{"groupId":"OG001","value":"104","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":134},"commonTop":[]}}}